Reproducibility of plasma angiotensin-converting enzyme activity in human subjects determined by fluorimetry with Z-phenylalanine-histidyl-leucine as substrate

被引:14
作者
Jalil, JE
Ocaranza, MP
Piddo, AM
Jalil, R
机构
[1] Pontificia Univ Catolica Chile, Dept Cardiovasc Dis, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Dept Nephrol, Santiago, Chile
来源
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1999年 / 133卷 / 05期
关键词
D O I
10.1016/S0022-2143(99)90027-6
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Despite the major physiologic role of angiotensin-converting enzyme (ACE), few studies have evaluated the ideal conditions for measuring human plasma ACE activity specifically when using Z-phenylalanine-histidyl-leucine as substrate. This study, performed in volunteer patients. assessed the reproducibility of human plasma ACE activity measured by fluorimetry with Z-phenyl-histidyl-leucine as the substrate. After blood centrifugation, plasma was stored under different conditions until processing. The following sources of variability were evaluated: (1) the interval to centrifugation of blood after collection, (2) the temperature and (3) safe time for storing the plasma after cold centrifugation, (4) the effect of tasting. Plasma ACE activity was 20.6 +/- 7.7 U/ml, 20.9 +/- 8 U/mL, and 20.5 +/- 7.9 U/mL (n = 25) when samples were centrifuged immediately, after 1 hour of blood sampling, and after 3 hours of blood sampling, respectively (not significant). In plasma kept at -20 degrees C, ACE activity was not different after 1 week (17.4 +/- 4.3 U/mL) nor after 1 month (17.9 +/- 4 U/mL), whereas baseline ACE was 16.7 +/- 4.3 U/mL (n = 10). In plasma stored at -80 degrees C, ACE activity was 15.5 +/- 5.7 U/mL after 1 month (baseline 15 +/- 5.3 U/mL; not significant; n = 12). No evidence for hydrolysis of the reaction product of ACE (his-leu dipeptide) was observed in plasma samples kept for 1 month at -20 degrees C or at -80 degrees C (by high-performance liquid chromatography analysis). In plasma obtained before breakfast, ACE activity was 12.8 +/- 7.1 U/mL, and it was 12.3 +/- 7.5 U/mL 2 hours afterwards (not significant; n = 12), Thus, to determine human plasma ACE activity by fluorimetry with reliability, with Z-phenylalanine-histidyl-leucine used as a substrate, there is a safe interval of at least 3 hours before blood centrifugation at -4 degrees C. Plasma may be kept at -20 degrees C or at -80 degrees C for at least 4 weeks before final processing. Easting does not influence its enzymatic activity.
引用
收藏
页码:501 / 506
页数:6
相关论文
共 19 条
[1]  
ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33
[2]  
ALHENCGELAS F, 1983, J LAB CLIN MED, V101, P83
[3]   PLASMA-LEVEL AND GENE POLYMORPHISM OF ANGIOTENSIN-CONVERTING ENZYME IN RELATION TO MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
COSTEROUSSE, O ;
TIRET, L ;
POIRIER, O ;
LECERF, L ;
GONZALES, MF ;
EVANS, A ;
ARVEILER, D ;
CAMBOU, JP ;
LUC, G ;
RAKOTOVAO, R ;
DUCIMETIERE, P ;
SOUBRIER, F ;
ALHENC-GELAS, F .
CIRCULATION, 1994, 90 (02) :669-676
[4]  
CAMBIEN F, 1988, AM J HUM GENET, V43, P774
[5]   REGULATION OF ACE GENE-EXPRESSION AND PLASMA-LEVELS DURING RAT POSTNATAL-DEVELOPMENT [J].
COSTEROUSSE, O ;
ALLEGRINI, J ;
HUANG, HM ;
BOUNHIK, J ;
ALHENCGELAS, F .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1994, 267 (05) :E745-E753
[6]   Genetics of angiotensin I-converting enzyme [J].
Costerousse, O ;
Danilov, S ;
AlhencGelas, F .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1997, 19 (5-6) :659-669
[7]   ANGIOTENSIN-I-CONVERTING ENZYME IN HUMAN CIRCULATING MONONUCLEAR-CELLS - GENETIC-POLYMORPHISM OF EXPRESSION IN LYMPHOCYTES-T [J].
COSTEROUSSE, O ;
ALLEGRINI, J ;
LOPEZ, M ;
ALHENCGELAS, F .
BIOCHEMICAL JOURNAL, 1993, 290 :33-40
[8]   SPECTROPHOTOMETRIC ASSAY AND PROPERTIES OF ANGIOTENSIN-CONVERTING ENZYME OF RABBIT LUNG [J].
CUSHMAN, DW ;
CHEUNG, HS .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (07) :1637-+
[9]   Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studies [J].
Danilov, S ;
Savoie, F ;
Lenoir, B ;
Jeunemaitre, X ;
Azizi, M ;
Tarnow, L ;
AlhencGelas, F .
JOURNAL OF HYPERTENSION, 1996, 14 (06) :719-727
[10]  
FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416